SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences informs about outcome of board meeting

03 Jul 2025 Evaluate
Suven Life Sciences has informed that the Board of Directors of the Company in its meeting held today,  03rd July, 2025 has allotted 6,40,02,999 (Six crores forty lakhs two thousand nine hundred and ninety nine) convertible Warrants to 23 allottees as listed in the annexure, at an issue price of Rs 134 per warrant on preferential basis upon receipt of the amount equivalent to at least 25% of the Warrant Issue Price, total Rs 214,41,00,466.50 (Rupees Two Hundred and Fourteen Crores Forty-One Lakhs Four Hundred Sixty-Six and Fifty paisa only), in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

194.65 16.35 (9.17%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×